There is at least one other that has received approval.
https://www.globenewswire.com/news-release/2020/11/27/2135269/0/en/Rhythm-Pharmaceuticals-Announces-FDA-Approval-of-IMCIVREE-setmelanotide-as-First-ever-Therapy-for-Chronic-Weight-Management-in-Patients-with-Obesity-Due-to-POMC-PCSK1-or-LEPR-Defic.html
Ann: Change of Director's Interest Notice, page-23
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.44 |
Change
-0.180(1.15%) |
Mkt cap ! $773.2M | |||
| Open | High | Low | Value | Volume |
| $15.60 | $15.75 | $15.39 | $751.4K | 48.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 173 | $15.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.54 | 209 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |